Media & Downloads

Introducing Nu.Q^® NETs: Precision Biomarker Across Acute and Chronic Care.

February 18, 2026

Share
Tweet
Share on Facebook
Share

Nu.Q® NETs is a biomarker-driven solution designed to help clinicians and researchers anticipate disease progression, guide treatment decisions, and monitor patients over time. Applicable across both acute and chronic conditions, it supports more informed, personalized approaches to patient care.

Download

Press Releases
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference
Videos
Video: Transcription Factor DNA in Plasma New Data Revealed

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:*

Animal Health

Human Health

Name*

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Introducing Nu.Q^® NETs: Precision Biomarker Across Acute and Chronic Care.

Related Articles

Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference

Video: Transcription Factor DNA in Plasma New Data Revealed

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact